###BASE_URL###

GENET-news

To stay informed you can subscribe to the GENET-news list.

 

2015-11-05 |

Synthetic biology lures Silicon Valley investors

In 2012, Emily Leproust was trying to raise money to start Twist Bioscience, a company that aimed to synthesize DNA more quickly and more cheaply than existing methods allowed. But many investors were spooked by the perception that synthetic biology — the engineering of microorganisms to make useful products such as drugs, food ingredients and materials — would not turn a profit. “It was a lonely time,” Leproust recalls.

Overview

News

2015-11-05 |

Synthetic biology lures Silicon Valley investors

In 2012, Emily Leproust was trying to raise money to start Twist Bioscience, a company that aimed to synthesize DNA more quickly and more cheaply than existing methods allowed. But many investors were spooked by the perception that synthetic biology — the engineering of microorganisms to make useful products such as drugs, food ingredients and materials — would not turn a profit. “It was a lonely time,” Leproust recalls.

Home: GENET

GENET-news & GENET-forum

GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by  email.

The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the  coordinator for membership and subscription.